ConductScience.org, home

Paper39478665

Perspective for Drug Discovery Targeting SARS Coronavirus Methyltransferases: Function, Structure and Inhibition.

Li X and 1 other. J Med Chem, 2024. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Perspective for Drug Discovery Targeting SARS Coronavirus Methyltransferases: Function, Structure and Inhibition. Papers, record 39478665. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39478665

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Perspective for Drug Discovery Targeting SARS Coronavirus Methyltransferases: Function, Structure and Inhibition.
PubMed
Journal
J Med Chem
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
1.22, provisional
iCite
Revised in PubMed
2026-06-04
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li XXinhttps://orcid.org/0000-0002-0189-4371
2Song YYongchenghttps://orcid.org/0000-0003-2611-2476

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MethyltransferasesMajor topic
Antiviral AgentsMajor topic
Drug DiscoveryMajor topic
SARS-CoV-2Major topic
Severe acute respiratory syndrome-related coronavirusMajor topic
Humans
COVID-19 Drug Treatment
COVID-19
Enzyme Inhibitors
Viral Nonstructural Proteins

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA266057NCI NIH HHSUnited StatesR01CA266057PubMedNIH RePORTER
R21 AI159323NIAID NIH HHSUnited StatesR21AI159323PubMedNIH RePORTER
RP220232NIHPubMedPubMed

Download CSV of grants

References118

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136546776Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal details of exoribonuclease activation and mRNA capping and provide starting points for antiviral drug development.Nucleic Acids Res2023https://conductscience.org/library/papers/36546776PubMed
233724070Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry.SLAS Discov2021https://conductscience.org/library/papers/33724070PubMed
325626080RNA methyltransferases involved in 5' cap biosynthesis.RNA Biol2014https://conductscience.org/library/papers/25626080PubMed
437659195Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review.Eur J Med Chem2023https://conductscience.org/library/papers/37659195PubMed
534845015Structure-function analysis of the nsp14 N7-guanine methyltransferase reveals an essential role in Betacoronavirus replication.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/34845015PubMed
634641339Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19.Molecules2021https://conductscience.org/library/papers/34641339PubMed
732075877Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.Science2020https://conductscience.org/library/papers/32075877PubMed
832259329Direct High-Throughput Screening Assay for mRNA Cap Guanine-N7 Methyltransferase Activity.Chemistry2020https://conductscience.org/library/papers/32259329PubMed
915629030Complete genome sequences of the SARS-CoV: the BJ Group (Isolates BJ01-BJ04).Genomics Proteomics Bioinformatics2003https://conductscience.org/library/papers/15629030PubMed
1036764586SS148 and WZ16 inhibit the activities of nsp10-nsp16 complexes from all seven human pathogenic coronaviruses.Biochim Biophys Acta Gen Subj2023https://conductscience.org/library/papers/36764586PubMed
1137683636Multidrug-resistant mutations to antiviral and antibody therapy in an immunocompromised patient infected with SARS-CoV-2.Med2023https://conductscience.org/library/papers/37683636PubMed
1232201080Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection.Biochem Biophys Res Commun2020https://conductscience.org/library/papers/32201080PubMed
1332439197COVID-19 and Multiorgan Response.Curr Probl Cardiol2020https://conductscience.org/library/papers/32439197PubMed
1412690092A novel coronavirus associated with severe acute respiratory syndrome.N Engl J Med2003https://conductscience.org/library/papers/12690092PubMed
1518255185The SARS-Coronavirus PLnc domain of nsp3 as a replication/transcription scaffolding protein.Virus Res2008https://conductscience.org/library/papers/18255185PubMed
1635439007Potent Inhibition of SARS-CoV-2 nsp14 N7-Methyltransferase by Sulfonamide-Based Bisubstrate Analogues.J Med Chem2022https://conductscience.org/library/papers/35439007PubMed
1734131072Mn2+ coordinates Cap-0-RNA to align substrates for efficient 2'-O-methyl transfer by SARS-CoV-2 nsp16.Sci Signal2021https://conductscience.org/library/papers/34131072PubMed
1836075969High-resolution structures of the SARS-CoV-2 N7-methyltransferase inform therapeutic development.Nat Struct Mol Biol2022https://conductscience.org/library/papers/36075969PubMed
1932563813Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase.Eur J Med Chem2020https://conductscience.org/library/papers/32563813PubMed
2031986257A novel coronavirus outbreak of global health concern.Lancet2020https://conductscience.org/library/papers/31986257PubMed

See all 118 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42921030Structure-Based Design of New Nonpeptidic Covalent Mpro Inhibitors against SARS-CoV‑2 and Omicron Variants.ACS Bio Med Chem Au2026https://conductscience.org/library/papers/42921030PubMed
42123558From Epigenetic Regulation to Protein Degradation: Emerging Strategies for Anti-Infective Drug Discovery.Int J Mol Sci2026https://conductscience.org/library/papers/42123558PubMed
41337461Moringa oleifera potential for the treatment and prevention of COVID-19 involving molecular interaction, antioxidant properties and kinetic mechanism.PLoS One2025https://conductscience.org/library/papers/41337461PubMed
41184286SARS-CoV-2 NSP14 inhibitor exhibits potent antiviral activity and reverses NSP14-driven host modulation.Nat Commun2025https://conductscience.org/library/papers/41184286PubMed
40910582Discovery, Optimization, and Evaluation of Non-Nucleoside SARS-CoV-2 NSP14 Inhibitors.J Med Chem2025https://conductscience.org/library/papers/40910582PubMed
40143346Structural Virology: The Key Determinants in Development of Antiviral Therapeutics.Viruses2025https://conductscience.org/library/papers/40143346PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39478665

GET https://conductscience.org/api/papers/v1/39478665/references?page=2